VP and CFO of HiTech Pharmacal Co. Inc. (HITK, Financial) William J Peters sells 10,800 shares of HITK on 09/30/2009 at an average price of $22.81 a share.
Hi-Tech is a specialty pharmaceutical company developing manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $244.4 million; its shares were traded at around $21.45 with a P/E ratio of 16.7 and P/S ratio of 2.3.
Recent Trades of HiTech Pharmacal Co. Inc. by CEO:
Recent Trades of HiTech Pharmacal Co. Inc. by CFO:
Recent Trades of HiTech Pharmacal Co. Inc. by Directors and Officers:
Hi-Tech is a specialty pharmaceutical company developing manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $244.4 million; its shares were traded at around $21.45 with a P/E ratio of 16.7 and P/S ratio of 2.3.
Recent Trades of HiTech Pharmacal Co. Inc. by CEO:
- Sell: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 40,000 shares of HITK stock on 09/29/2009 at the average price of $21.49; the price of the stock has decreased by 0.19% since.
- Sell: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 153,776 more shares of HITK stock on 09/15/2009 at the average price of $21.05; the price of the stock has increased by 1.9% since.
- Sell: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 16,224 more shares of HITK stock on 07/16/2009 at the average price of $12.66; the price of the stock has increased by 69.43% since.
Recent Trades of HiTech Pharmacal Co. Inc. by CFO:
- Sell: VP and CFO William J Peters sold 56,250 shares of HITK stock on 09/11/2009 at the average price of $21.86; the price of the stock has decreased by 1.88% since.
Recent Trades of HiTech Pharmacal Co. Inc. by Directors and Officers:
- Sell: Director Martin M Goldwyn sold 1,000 shares of HITK stock on 09/30/2009 at the average price of $22.11; the price of the stock has decreased by 2.99% since.
- Sell: Director Reuben Seltzer sold 35,401 shares of HITK stock on 09/29/2009 at the average price of $21.77; the price of the stock has decreased by 1.47% since.
- Sell: Director Bruce W Simpson sold 15,187 shares of HITK stock on 09/17/2009 at the average price of $19.13; the price of the stock has increased by 12.13% since.
- Sell: President, HCP Division Gary M April sold 54,843 shares of HITK stock on 09/17/2009 at the average price of $20.58; the price of the stock has increased by 4.23% since.
- Sell: Director, 10% Owner Reuben Seltzer sold 72,000 shares of HITK stock on 09/15/2009 at the average price of $21.02; the price of the stock has increased by 2.05% since.
